天然产物研究与开发 ›› 2024, Vol. 36 ›› Issue (增刊2): 114-121.

• 数据研究 • 上一篇    下一篇

基于网络药理学和分子对接探讨利肺片治疗慢性气管炎的作用机制

许哲雨1,周   洁2,余惠凡3*   

  1. 1湖北文理学院附属谷城医院肾病科;2湖北文理学院附属谷城医院药剂科,襄阳 441700;3湖北医药学院药学院 武当特色中药研究湖北省重点实验室,十堰 442000
  • 出版日期:2024-12-09 发布日期:2024-12-09
  • 基金资助:
    十堰市引导性科研项目(19Y13);湖北医药学院人才启动金项目(2018QDJZR29)

Mechanism of Lifei tablets in treating chronic bronchitis based on network pharmacology and molecular docking

XU Zhe-yu1,ZHOU Jie2,YU Hui-fan3*   

  1. 1Department of Nephrology, Gucheng Hospital, Hubei University of Arts and Science; 2Department of Pharmacy, Gucheng Hospital, Hubei University of Arts and Science, Xiangyang 441700, China; 3Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan 442000, China
  • Online:2024-12-09 Published:2024-12-09

摘要:

利用网络药理学和分子对接技术探讨利肺片治疗慢性气管炎的潜在作用机制。运用中药系统药理学数据库与分析平台(TCMSP)、在线人类孟德尔遗传数据库(OMIM)及DisGent数据库查找利肺片有效成分及慢性气管炎基因靶点,应用STRING、MetaScape平台构建蛋白质互作(PPI)网络及利肺片治疗慢性气管炎活性成分-共同靶点-信号通路网络,共获得利肺片128个活性成分,活性成分相关靶点531个,疾病相关靶点174个,交集靶点33个,其中核心治疗靶点10个。对交集靶点进行分析,其中GO富集分析共得生物过程2 548条,分子功能191个,细胞组成97个。综上所述,利肺片可能是通过调节TNF、TP53、CXCL8、IL1B、IL6、IL4、IL1、CD4等靶点,参与细胞质内调控因子的合成与转运从而控制细胞增殖凋亡来改善慢性气管炎病情。

关键词: 利肺片, 网络药理学, 慢性气管炎, 分子对接

Abstract:

This study aims to explore the potential mechanism of Lifei tablets in the treatment of chronic bronchitis through network pharmacology and molecular docking methods. CMSP, OMIM and DisGent databases were used to find the active components and gene targets for chronic bronchitis.STRING and MetaScape platforms were used to construct the protein interaction (PPI) network and the active ingredient-common target-signal pathway network of Lifei Tablet for the treatment of chronic bronchitis.A total of 128 active ingredients,531 active ingredient related targets,174 disease related targets,and 33 intersection targets were obtained.There were ten core therapeutic targets.The intersection targets were analyzed,among which 2 548 biological processes,191 molecular functions and 97 cell compositions were obtained by GO enrichment analysis. In summary,Lifei tablets may regulate targets such as TNF,TP53,CXCL8,IL1B,IL6,IL4,IL1 and CD4,and participate in the synthesis and transport of cytoplasmic regulatory factors,thereby controlling cell proliferation and apoptosis to improve the condition of chronic bronchitis.

Key words: Lifei tablet, network pharmacology, chronic bronchitis, molecular docking

中图分类号:  R285